Insufficient scRNA-seq data for expression of CBARP at single-cell level.
Insufficient scRNA-seq data for expression of CBARP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 97% | 1680.75 | 2570 / 2642 | 100% | 12.86 | 703 / 705 |
| skin | 98% | 572.12 | 1776 / 1809 | 94% | 4.41 | 445 / 472 |
| esophagus | 38% | 114.72 | 542 / 1445 | 87% | 4.75 | 159 / 183 |
| thymus | 52% | 135.48 | 339 / 653 | 65% | 1.35 | 392 / 605 |
| adrenal gland | 47% | 411.47 | 120 / 258 | 70% | 9.15 | 161 / 230 |
| ovary | 54% | 1062.97 | 98 / 180 | 60% | 1.72 | 257 / 430 |
| lung | 40% | 192.46 | 233 / 578 | 58% | 1.51 | 675 / 1155 |
| eye | 0% | 0 | 0 / 0 | 98% | 2.88 | 78 / 80 |
| kidney | 75% | 341.83 | 67 / 89 | 18% | 0.51 | 162 / 901 |
| stomach | 16% | 40.74 | 59 / 359 | 53% | 1.66 | 152 / 286 |
| intestine | 24% | 58.48 | 228 / 966 | 43% | 1.22 | 225 / 527 |
| bladder | 19% | 51.05 | 4 / 21 | 46% | 0.97 | 233 / 504 |
| prostate | 52% | 164.61 | 128 / 245 | 9% | 0.20 | 47 / 502 |
| breast | 27% | 69.02 | 122 / 459 | 33% | 0.61 | 372 / 1118 |
| uterus | 18% | 45.61 | 31 / 170 | 41% | 1.19 | 186 / 459 |
| pancreas | 6% | 12.97 | 21 / 328 | 44% | 1.03 | 79 / 178 |
| heart | 43% | 160.10 | 369 / 861 | 0% | 0 | 0 / 0 |
| adipose | 38% | 160.01 | 452 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 34% | 101.20 | 457 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 20% | 0.31 | 9 / 45 |
| liver | 4% | 12.27 | 9 / 226 | 7% | 0.13 | 30 / 406 |
| muscle | 8% | 18.44 | 63 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.04 | 1 / 29 |
| peripheral blood | 3% | 6.26 | 27 / 929 | 0% | 0 | 0 / 0 |
| spleen | 2% | 7.27 | 5 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1901386 | Biological process | negative regulation of voltage-gated calcium channel activity |
| GO_0045955 | Biological process | negative regulation of calcium ion-dependent exocytosis |
| GO_1903170 | Biological process | negative regulation of calcium ion transmembrane transport |
| GO_0030141 | Cellular component | secretory granule |
| GO_0030672 | Cellular component | synaptic vesicle membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0030426 | Cellular component | growth cone |
| GO_0044325 | Molecular function | transmembrane transporter binding |
| Gene name | CBARP |
| Protein name | Voltage-dependent calcium channel beta subunit-associated regulatory protein CACN subunit beta associated regulatory protein |
| Synonyms | C19orf26 |
| Description | FUNCTION: Negatively regulates voltage-gated calcium channels by preventing the interaction between their alpha and beta subunits. Thereby, negatively regulates calcium channels activity at the plasma membrane and indirectly inhibits calcium-regulated exocytosis. . |
| Accessions | ENST00000648750.1 Q8N350 ENST00000650044.2 [Q8N350-3] ENST00000382477.6 ENST00000591127.1 A0A140LJL2 K7ELJ5 ENST00000590083.5 [Q8N350-4] A0A3B3IRU5 |